All other measured parameters, including CD3+CD4+ T cell count, CD3+CD8+ T cell count, CD3-CD19+ B cell count, and CD3+CD56+ NK cell count, were significantly lower in COVID-19 patients compared to the control group (Figure 4A). This evidence concerns the gene NCAM1 and COVID-19.